Dose-ranging Study of Ramosetron for the Prevention of Nausea and Vomiting After Gynecologic Laparoscopic Surgery

NCT02478645 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

177

Enrollment

OTHER

Sponsor class

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG: ramosetron 0.3
DRUG: ramosetron 0.45
DRUG: ramosetron 0.6

Sponsor

Yonsei University